-
1
-
-
0029070836
-
Multimodal treatment for squamous cell esophageal cancer
-
Fink U, Stein HJ, Wilke H, Roder JD, Siewert JR. Multimodal treatment for squamous cell esophageal cancer. World J Surg 1995;19:198-204.
-
(1995)
World J Surg
, vol.19
, pp. 198-204
-
-
Fink, U.1
Stein, H.J.2
Wilke, H.3
Roder, J.D.4
Siewert, J.R.5
-
2
-
-
0028129581
-
Contributions of chemotherapy in the treatment of carcinoma of the esophagus: Results and commentary
-
Ajani JA. Contributions of chemotherapy in the treatment of carcinoma of the esophagus: Results and commentary. Semin Oncol 1994;21:474-82.
-
(1994)
Semin Oncol
, vol.21
, pp. 474-482
-
-
Ajani, J.A.1
-
5
-
-
0028212856
-
Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus
-
Roder JD, Busch R, Stein HJ, Fink U, Siewert JR. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994;81:410-3.
-
(1994)
Br J Surg
, vol.81
, pp. 410-413
-
-
Roder, J.D.1
Busch, R.2
Stein, H.J.3
Fink, U.4
Siewert, J.R.5
-
6
-
-
0031893891
-
The number of lymph node metastases influences survival in esophageal cancer
-
Kawahara K, Maekawa T, Okabayashi K, Shiraishi T, Yoshinaga Y, Yoneda S, et al. The number of lymph node metastases influences survival in esophageal cancer. J Surg Oncol 1998;67:160-3.
-
(1998)
J Surg Oncol
, vol.67
, pp. 160-163
-
-
Kawahara, K.1
Maekawa, T.2
Okabayashi, K.3
Shiraishi, T.4
Yoshinaga, Y.5
Yoneda, S.6
-
7
-
-
0033396574
-
Number of lymph node metastases influences survival in patients with thoracic esophageal carcinoma: Therapeutic value of radiation treatment for recurrence
-
Kimura H, Konishi K, Arakawa H, Oonishi I, Kaji M, Maeda K, et al. Number of lymph node metastases influences survival in patients with thoracic esophageal carcinoma: Therapeutic value of radiation treatment for recurrence. Dis Esophagus 1999;12:205-8.
-
(1999)
Dis Esophagus
, vol.12
, pp. 205-208
-
-
Kimura, H.1
Konishi, K.2
Arakawa, H.3
Oonishi, I.4
Kaji, M.5
Maeda, K.6
-
8
-
-
0029077969
-
Chemotherapy and multimodality therapy in the treatment of esophageal cancer
-
(in Japanese)
-
Ando N, Ozawa S, Kitajima M, Iizuka T. Chemotherapy and multimodality therapy in the treatment of esophageal cancer. Gan To Kagaku Ryoho 1995;22:869-76 (in Japanese).
-
(1995)
Gan To Kagaku Ryoho
, vol.22
, pp. 869-876
-
-
Ando, N.1
Ozawa, S.2
Kitajima, M.3
Iizuka, T.4
-
9
-
-
0023629840
-
Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer
-
Kies MS, Rosen ST, Tsang TK, Shetty R, Schneider PA, Wallemark CB, et al. Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer. Cancer 1987;60:2156-60.
-
(1987)
Cancer
, vol.60
, pp. 2156-2160
-
-
Kies, M.S.1
Rosen, S.T.2
Tsang, T.K.3
Shetty, R.4
Schneider, P.A.5
Wallemark, C.B.6
-
10
-
-
0026520727
-
Prolonged chemotherapy for localised squamous carcinoma of the oesophagus
-
Ajani JA, Ryan B, Rich TA, McMurtrey M, Roth JA, DeCaro L, et al. Prolonged chemotherapy for localised squamous carcinoma of the oesophagus. Eur J Cancer 1992;28A:880-4.
-
(1992)
Eur J Cancer
, vol.28 A
, pp. 880-884
-
-
Ajani, J.A.1
Ryan, B.2
Rich, T.A.3
McMurtrey, M.4
Roth, J.A.5
DeCaro, L.6
-
11
-
-
0026871235
-
Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: A Japanese Esophageal Oncology Group Trial
-
Iizuka T, Kakegawa T, Ide H, Ando N, Watanabe H, Tanaka O, et al. Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: A Japanese Esophageal Oncology Group Trial. Jpn J Clin Oncol 1992;22:172-6.
-
(1992)
Jpn J Clin Oncol
, vol.22
, pp. 172-176
-
-
Iizuka, T.1
Kakegawa, T.2
Ide, H.3
Ando, N.4
Watanabe, H.5
Tanaka, O.6
-
12
-
-
0026769381
-
Combined chemotherapy and radiotherapy compared with radio therapy alone in patients with cancer of the esophagus
-
Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radio therapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:1593-8.
-
(1992)
N Engl J Med
, vol.326
, pp. 1593-1598
-
-
Herskovic, A.1
Martz, K.2
al-Sarraf, M.3
Leichman, L.4
Brindle, J.5
Vaitkevicius, V.6
-
13
-
-
0031022804
-
Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study
-
al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study. J Clin Oncol 1997;15:277-84.
-
(1997)
J Clin Oncol
, vol.15
, pp. 277-284
-
-
al-Sarraf, M.1
Martz, K.2
Herskovic, A.3
Leichman, L.4
Brindle, J.S.5
Vaitkevicius, V.K.6
-
14
-
-
0000831060
-
Cancer of the esophagus
-
De Vita VT Jr, Hellman S, Rosenberg S, editors. 5th ed. Philadelphia, PA: Lippincott
-
Putnam SB Jr, Rich TA, Forastiere AA. Cancer of the esophagus. In: De Vita VT Jr, Hellman S, Rosenberg S, editors. Cancer: Principles and Practice of Oncology, 5th ed. Philadelphia, PA: Lippincott 1997;980-1021.
-
(1997)
Cancer: Principles and Practice of Oncology
, pp. 980-1021
-
-
Putnam Jr., S.B.1
Rich, T.A.2
Forastiere, A.A.3
|